Skip to content

Clotting Factor-VIII-IX-XI-XII Deficient Plasma

by Behring Diagnostics, Inc.

510(k) K924396

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

2 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 11 Oct 2026. What this means

Regulatory status

as of registry sync 11 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK924396 Date21 May 1993ClearedStatusActive

Recalls

2 recalls · FDA

    • Terminated Z-1713-2015 FDA Class II initiated 11 May 2015

    Discrepancies for Siemens BCS / BCS XP with dilution studies; erroneously high Factor IX results at the lower end of the measuring range.

    • Terminated Z-1374-05 FDA Unclassified (pre-2012) initiated 8 Jul 2005

    sample may exhibit falsely high results

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
GJT
Device Class
Class II
Regulation
21 CFR Part 864.7290
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Other devices from Behring Diagnostics, Inc.

See all devices from Behring Diagnostics, Inc. →